News

Sudeep Pharma announced that the Board of Directors of the Company at its meeting held on 21 May 2026, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 150%) , subject to the approval of the shareholders.

Net profit of Sudeep Pharma rose 10.61% to Rs 48.88 crore in the quarter ended March 2026 as against Rs 44.19 crore during the previous quarter ended March 2025. Sales rose 15.73% to Rs 182.34 crore in the quarter ended March 2026 as against Rs 157.55 crore during the previous quarter ended March 2025.For the full year,net profit rose 24.62% to Rs 172.89 crore in the year ended March 2026 as against Rs 138.73 crore during the previous year ended March 2025. Sales rose 27.94% to Rs 642.26 crore in the year ended March 2026 as against Rs 502.00 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales182.34157.55 16 642.26502.00 28 OPM %34.3337.31 -34.5537.84 - PBDT66.5860.68 10 242.88193.44 26 PBT62.6957.85 8 228.07182.85 25 NP48.8844.19 11 172.89138.73 25 Powered by Capital Market - Live News

Sudeep Pharma will hold a meeting of the Board of Directors of the Company on 21 May 2026.

Net profit of Sudeep Pharma rose 65.31% to Rs 47.46 crore in the quarter ended December 2025 as against Rs 28.71 crore during the previous quarter ended December 2024. Sales rose 49.16% to Rs 172.34 crore in the quarter ended December 2025 as against Rs 115.54 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales172.34115.54 49 OPM %34.8034.01 - PBDT65.6440.32 63 PBT61.7837.66 64 NP47.4628.71 65 Powered by Capital Market - Live News

Sudeep Pharma will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live News